Rhinosporidium seeberi: A Human Pathogen from a Novel Group of Aquatic Protistan Parasites
David N. Fredricks,*† Jennifer A. Jolley,* Paul W. Lepp,* Jon C. Kosek,† and David A.
Relman*† *Stanford University, Stanford, California, USA; and †Veterans Affairs, Palo Alto Health Care System, Palo Alto, California, USA
Figure 3. Agarose gel electrophoresis of Rhinosporidium-specific PCR products. The specific amplification product is 377
bp. No amplification product
is seen in the negative control samples consisting of water (reagent-only control), digestion buffer (DB), or lymph node tissue control
(Tis Cnt). The
human rhinosporidiosis samples (RS1-3) and the original canine nasal polyp show visible amplification products.
